141 related articles for article (PubMed ID: 8848890)
1. Reversal of atracurium-induced neuromuscular block in paediatric patients.
Kirkegaard-Nielsen H; Meretoja OA; Wirtavuori K
Acta Anaesthesiol Scand; 1995 Oct; 39(7):906-11. PubMed ID: 8848890
[TBL] [Abstract][Full Text] [Related]
2. Neostigmine and edrophonium as antagonists of atracurium and pancuronium.
Sanfilippo M; Vilardi V; Fierro G; Rosa G; Pelaia P; Gasparetto A
Acta Anaesthesiol Scand; 1988 Aug; 32(6):437-40. PubMed ID: 2845694
[TBL] [Abstract][Full Text] [Related]
3. A comparison of edrophonium and neostigmine for the antagonism of atracurium-induced neuromuscular block.
Lavery GG; Mirakhur RK; Gibson FM
Anesth Analg; 1985 Sep; 64(9):867-70. PubMed ID: 3161421
[TBL] [Abstract][Full Text] [Related]
4. Time to peak effect of neostigmine at antagonism of atracurium- or vecuronium-induced neuromuscular block.
Kirkegaard-Nielsen H; Helbo-Hansen HS; Lindholm P; Severinsen IK; Bülow K
J Clin Anesth; 1995 Dec; 7(8):635-9. PubMed ID: 8747561
[TBL] [Abstract][Full Text] [Related]
5. Dose-response relationships for edrophonium and neostigmine antagonism of atracurium and cisatracurium-induced neuromuscular block.
Naguib M; Riad W
Can J Anaesth; 2000 Nov; 47(11):1074-81. PubMed ID: 11097536
[TBL] [Abstract][Full Text] [Related]
6. Antagonism of intense atracurium-induced neuromuscular block in children.
Gwinnutt CL; Walker RW; Meakin G
Br J Anaesth; 1991 Jul; 67(1):13-6. PubMed ID: 1859751
[TBL] [Abstract][Full Text] [Related]
7. Recovery characteristics following antagonism of atracurium with neostigmine or edrophonium.
Jones RM; Pearce AC; Williams JP
Br J Anaesth; 1984 May; 56(5):453-7. PubMed ID: 6326785
[TBL] [Abstract][Full Text] [Related]
8. Dose-response relationships for edrophonium and neostigmine as antagonists of atracurium and vecuronium neuromuscular blockade.
Smith CE; Donati F; Bevan DR
Anesthesiology; 1989 Jul; 71(1):37-43. PubMed ID: 2568767
[TBL] [Abstract][Full Text] [Related]
9. Atracurium after an anticholinesterase. Does prior reversal with edrophonium or neostigmine influence the response to atracurium?
Shorten GD; Ali HA
Anaesthesia; 1993 Jun; 48(6):524-6. PubMed ID: 8322995
[TBL] [Abstract][Full Text] [Related]
10. Dose-response relationships for edrophonium and neostigmine antagonism of mivacurium-induced neuromuscular block.
Naguib M; Abdulatif M; al-Ghamdi A; Hamo I; Nouheid R
Br J Anaesth; 1993 Nov; 71(5):709-14. PubMed ID: 8251285
[TBL] [Abstract][Full Text] [Related]
11. Dose-response relationships for edrophonium and neostigmine as antagonists of moderate and profound atracurium blockade.
Donati F; Smith CE; Bevan DR
Anesth Analg; 1989 Jan; 68(1):13-9. PubMed ID: 2910133
[TBL] [Abstract][Full Text] [Related]
12. Is recovery of neuromuscular transmission complete after the use of neostigmine to antagonize block produced by rocuronium, vecuronium, atracurium and pancuronium?
Baurain MJ; Hoton F; D'Hollander AA; Cantraine FR
Br J Anaesth; 1996 Oct; 77(4):496-9. PubMed ID: 8942335
[TBL] [Abstract][Full Text] [Related]
13. Antagonism of vecuronium and atracurium: comparison of neostigmine and edrophonium administered at 5% twitch height recovery.
Caldwell JE; Robertson EN; Baird WL
Br J Anaesth; 1987 Apr; 59(4):478-81. PubMed ID: 2882769
[TBL] [Abstract][Full Text] [Related]
14. Priming reversal of profound atracurium blockade by edrophonium and neostigmine.
Liu CH; Lin IS; Liu CG; Peng TH; Yeh YJ; Chuu LJ; Lin SY
Gaoxiong Yi Xue Ke Xue Za Zhi; 1995 May; 11(5):257-64. PubMed ID: 7602663
[TBL] [Abstract][Full Text] [Related]
15. Dose-response relationships for edrophonium and neostigmine antagonism of rocuronium bromide (ORG 9426)-induced neuromuscular blockade.
Naguib M; Abdulatif M; al-Ghamdi A
Anesthesiology; 1993 Oct; 79(4):739-45. PubMed ID: 8214753
[TBL] [Abstract][Full Text] [Related]
16. Antagonism of atracurium-induced block in obese patients.
Kirkegaard-Nielsen H; Lindholm P; Petersen HS; Severinsen IK
Can J Anaesth; 1998 Jan; 45(1):39-41. PubMed ID: 9466025
[TBL] [Abstract][Full Text] [Related]
17. A comparison of cisatracurium and atracurium: onset of neuromuscular block after bolus injection and recovery after subsequent infusion.
Mellinghoff H; Radbruch L; Diefenbach C; Buzello W
Anesth Analg; 1996 Nov; 83(5):1072-5. PubMed ID: 8895288
[TBL] [Abstract][Full Text] [Related]
18. Neostigmine and edrophonium antagonism of varying intensity neuromuscular blockade induced by atracurium, pancuronium, or vecuronium.
Rupp SM; McChristian JW; Miller RD; Taboada JA; Cronnelly R
Anesthesiology; 1986 Jun; 64(6):711-7. PubMed ID: 2872839
[TBL] [Abstract][Full Text] [Related]
19. Recovery times following edrophonium and neostigmine reversal of pancuronium, atracurium, and vecuronium steady-state infusions.
Kopman AF
Anesthesiology; 1986 Dec; 65(6):572-8. PubMed ID: 2878631
[TBL] [Abstract][Full Text] [Related]
20. Optimum time for neostigmine reversal of atracurium-induced neuromuscular blockade.
Kirkegaard-Nielsen H; Helbo-Hansen HS; Lindholm P; Severinsen IK; Pedersen HS; Jensen EW
Can J Anaesth; 1996 Sep; 43(9):932-8. PubMed ID: 8874911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]